He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...

Transcarent CEO Glen Tullman spent much of 2024 hinting that his health benefits upstart might be shopping around for ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Tenvie Therapeutics is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug ...

The beleaguered Belgian firm Galapagos is splitting itself into two companies, with the brandname biotech prioritizing ...

In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...

The Beckman Foundation wanted to make sure it wasn’t unfairly prioritizing elite research institutions. So it tried something ...

The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

The FDA published its first draft guidance on the use of AI in the development of drugs and biological products ...